IGC Pharma, Inc. (IGC): Depreciation & Amortization
Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$618.0K
Year ended 2025-03-31
$571.0K
Trailing 12 months to 2025-09-30
-1.7%
3-year compound annual growth
+33.8%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-03-31 | $618.0K | -3.0% | 2025-06-27, From 2024-04-01 |
| 2024-03-31 | $637.0K | -3.0% | 2025-06-27, From 2023-04-01 |
| 2023-03-31 | $657.0K | +0.9% | 2024-06-24, From 2022-04-01 |
| 2022-03-31 | $651.0K | +36.2% | 2023-07-07, From 2021-04-01 |
| 2021-03-31 | $478.0K | +231.9% | 2022-06-23, From 2020-04-01 |
| 2020-03-31 | $144.0K | +144.1% | 2021-06-14, From 2019-04-01 |
| 2019-03-31 | $59.0K | +210.5% | 2020-07-13, From 2018-04-01 |
| 2018-03-31 | $19.0K | n/c | 2019-06-14, From 2017-04-01 |
| 2017-03-31 | $396.3K | -45.6% | 2018-06-21, From 2016-04-01 |
| 2016-03-31 | $728.7K | -6.8% | 2017-07-14, From 2015-04-01 |
| 2015-03-31 | $781.5K | +9.7% | 2016-07-14, From 2014-04-01 |
| 2014-03-31 | $712.3K | +5.7% | 2015-07-14, From 2013-04-01 |
| 2013-03-31 | $673.9K | -32.4% | 2014-07-15, From 2012-04-01 |
| 2012-03-31 | $996.4K | +26.9% | 2014-07-15, From 2011-04-01 |
| 2011-03-31 | $785.1K | n/a | 2012-07-16, From 2010-04-01 |